IL141050A0 - Muscarinic agonists and antagonists - Google Patents

Muscarinic agonists and antagonists

Info

Publication number
IL141050A0
IL141050A0 IL14105099A IL14105099A IL141050A0 IL 141050 A0 IL141050 A0 IL 141050A0 IL 14105099 A IL14105099 A IL 14105099A IL 14105099 A IL14105099 A IL 14105099A IL 141050 A0 IL141050 A0 IL 141050A0
Authority
IL
Israel
Prior art keywords
antagonists
muscarinic agonists
muscarinic
agonists
Prior art date
Application number
IL14105099A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL141050A0 publication Critical patent/IL141050A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14105099A 1998-08-18 1999-08-16 Muscarinic agonists and antagonists IL141050A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
IL141050A0 true IL141050A0 (en) 2002-02-10

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14105099A IL141050A0 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Country Status (30)

Country Link
US (5) US6093724A (bg)
EP (1) EP1112272B1 (bg)
JP (1) JP2002523416A (bg)
KR (1) KR20010072784A (bg)
CN (1) CN1312812A (bg)
AR (1) AR020199A1 (bg)
AT (1) ATE227724T1 (bg)
AU (1) AU750566B2 (bg)
BG (1) BG105256A (bg)
BR (1) BR9913072A (bg)
CA (1) CA2340946A1 (bg)
CO (1) CO5130018A1 (bg)
DE (1) DE69903961T2 (bg)
EE (1) EE200100096A (bg)
ES (1) ES2191455T3 (bg)
HK (1) HK1038918A1 (bg)
HU (1) HUP0103203A3 (bg)
ID (1) ID27544A (bg)
IL (1) IL141050A0 (bg)
IS (1) IS5827A (bg)
NO (1) NO20010804L (bg)
NZ (1) NZ509762A (bg)
PE (1) PE20000988A1 (bg)
PL (1) PL346247A1 (bg)
RU (1) RU2219179C2 (bg)
SK (1) SK1892001A3 (bg)
TR (1) TR200100462T2 (bg)
WO (1) WO2000011001A1 (bg)
YU (1) YU13301A (bg)
ZA (1) ZA200100978B (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03003475A (es) * 2000-10-19 2003-07-14 Pfizer Prod Inc Derivados puente de piperazina.
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
ES2391596T3 (es) * 2007-03-23 2012-11-28 Abbott Laboratories Derivados de azaadamantano 4-sustituidos y métodos de uso de los mismos
ES2378116T3 (es) 2007-03-23 2012-04-09 Abbott Laboratories Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos
CN102459268A (zh) * 2009-06-19 2012-05-16 雅培制药有限公司 二氮杂高金刚烷衍生物和其使用方法
HUE044653T2 (hu) 2009-07-22 2019-11-28 PureTech Health LLC Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AU2011305462B2 (en) 2010-09-23 2015-11-26 Abbvie Bahamas Ltd. Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3732163A4 (en) * 2017-12-20 2021-07-14 Vanderbilt University MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4
MX2021003621A (es) 2018-09-28 2022-04-13 Karuna Therapeutics Inc Composiciones y metodos para tratar trastornos mejorados por medio de activacion de receptor muscarinico.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
AU702720B2 (en) * 1995-11-02 1999-03-04 Neurosearch A/S Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
DE69903961T2 (de) 2003-07-03
TR200100462T2 (tr) 2001-09-21
WO2000011001A1 (en) 2000-03-02
AR020199A1 (es) 2002-05-02
KR20010072784A (ko) 2001-07-31
BG105256A (bg) 2001-11-30
JP2002523416A (ja) 2002-07-30
HUP0103203A2 (hu) 2002-01-28
CO5130018A1 (es) 2002-02-27
NO20010804L (no) 2001-04-11
ES2191455T3 (es) 2003-09-01
NO20010804D0 (no) 2001-02-16
US20020045617A1 (en) 2002-04-18
US6323194B1 (en) 2001-11-27
HUP0103203A3 (en) 2002-10-28
ZA200100978B (en) 2002-02-05
AU5775899A (en) 2000-03-14
US6423842B1 (en) 2002-07-23
BR9913072A (pt) 2001-05-15
HK1038918A1 (zh) 2002-04-04
EP1112272B1 (en) 2002-11-13
EP1112272A1 (en) 2001-07-04
NZ509762A (en) 2002-12-20
US6251916B1 (en) 2001-06-26
US6093724A (en) 2000-07-25
CN1312812A (zh) 2001-09-12
ATE227724T1 (de) 2002-11-15
IS5827A (is) 2001-01-26
AU750566B2 (en) 2002-07-25
RU2219179C2 (ru) 2003-12-20
PE20000988A1 (es) 2000-09-30
ID27544A (id) 2001-04-12
SK1892001A3 (en) 2001-11-06
CA2340946A1 (en) 2000-03-02
DE69903961D1 (de) 2002-12-19
US6555550B1 (en) 2003-04-29
EE200100096A (et) 2002-06-17
PL346247A1 (en) 2002-01-28
YU13301A (sh) 2005-06-10

Similar Documents

Publication Publication Date Title
IL139136A0 (en) Il-2 selective agonists and antagonists
PL331534A1 (en) Muscarinic antagonists
IL141050A0 (en) Muscarinic agonists and antagonists
SG85628A1 (en) Compound and its use
HK1042084B (zh) 取代的苯並咪唑及其製備和用途
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
IL140249A0 (en) Muscarinic antagonists
SG80041A1 (en) Muscarinic receptor antagonists
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AUPP380498A0 (en) Egf receptor agonists and antagonists
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB9803232D0 (en) Compound composition and use
HK1043590A1 (zh) 毒蕈碱性拮抗物
AU5861900A (en) Receptor agonists and antagonists
EP1242074A4 (en) NMDA / NR2B ANTAGONISTS BASED ON 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE
HUP0004317A3 (en) 5-ht1f agonists
AU9275001A (en) Notch receptor agonists and uses
GB9820014D0 (en) Receptor antagonists and uses thereof
GB9701374D0 (en) Purinergic agonists and antagonists
HU9902674D0 (en) Estrogen agonists/antagonists
IL137428A0 (en) Estrogen agonists and antagonists for multiple indications
PL307138A1 (en) Amyline antagonists and agonists